BRSYF OTC
BrainsWay Ltd.
1W: +0.0%
1M: +24.3%
3M: +45.9%
YTD: +92.9%
1Y: +395.3%
3Y: +321.0%
5Y: +321.0%
$16.84
+0.00 (+0.00%)
After Hours: $15.57 (-1.27, -7.54%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$674.3M
52W Range3.4-16.84
Volume300
Avg Volume18
Beta0.22
Dividend—
Analyst Ratings
Company Info
CEOHadar Levy
Employees120
SectorHealthcare
IndustryMedical - Devices
IPO Date2011-04-21
Websitebrainsway.com
Bynet Building
Jerusalem 9777518
IL
Jerusalem 9777518
IL
972 2 582 4030
About BrainsWay Ltd.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Latest News
Brainsway (NASDAQ:BWAY) Sets New 1-Year High – Here’s What Happened
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Large Drop in Short Interest
Brainsway (NASDAQ:BWAY) Sets New 52-Week High – Here’s Why
Equities Analysts Issue Forecasts for Brainsway Q1 Earnings
Brainsway (NASDAQ:BWAY) Reaches New 12-Month High on Better-Than-Expected Earnings
Recent Insider Trades
No insider trades found